Anupam Dalal's Net Worth
-$40.8 Million
Who is Anupam Dalal?
Anupam Dalal does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Aadi Bioscience, Inc., Neos Therapeutics, Inc., and Akebia Therapeutics, Inc..
SEC CIK
Anupam Dalal's CIK is 0001602474
Past Insider Trading and Trends
2021 was Anupam Dalal's most active year for acquiring shares with 6 total transactions. Anupam Dalal's most active month to acquire stocks was the month of May. 2015 was Anupam Dalal's most active year for disposing of shares, totalling 3 transactions. Anupam Dalal's most active month to dispose stocks was the month of June. 2021 saw Anupam Dalal paying a total of $40,022,476.37 for 3,108,900 shares, this is the most they've acquired in one year. In 2015 Anupam Dalal cashed out on 2,916,132 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Neos Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.22M |
—
|
—
| 1.22M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aadi Bioscience, Inc. (AADI) Snapshot price: $1.74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +20.92% | 320K |
$12.50 | $4,000,000.00 | 1.85M |
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4/A
|
∞
| 1.53M |
$13.08 | $19,999,989.95 | 1.53M |
Aug 26
| |||
Form 4
|
∞
| 1.53M |
$13.08 | $19,999,989.95 | 1.53M |
Aug 26 - Aug 27
| |||
Form 4
| +77.41% | 7.4K |
$1.52 | $11,248.00 | 16.96K |
Jun 30
| |||
Form 4
| +321.29% | 7.29K |
$1.54 | $11,248.47 | 9.56K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.66
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||